Fluticasone News
Fluticasone furoate spray curbs seasonal rhinitis
Daily use of a new side-actuated nasal spray containing the enhanced-affinity glucocorticoid fluticasone furoate is effective in treatment of nasal and ocular symptoms caused by seasonal allergic rhinitis, according to...
Skyepharma forced to delay NDA in US
SkyePharma will be delaying its New Drug Application (NDA) in the US for its asthma treatment Flutiform following an "unexpected" setback in the submission process.
FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years
The U.S. Food and Drug Administration approved once-daily Veramyst(TM) (fluticasone furoate) Nasal Spray on Friday to treat seasonal and year-round allergy symptoms in adults and children two years of age and older. Veramyst will...
Astrazeneca Launches A Smarter Approach To Asthma Management In Europe
AstraZeneca today announced that 37 countries to date have received approval of SymbicortŪ Maintenance And Reliever Therapy (Symbicort SMARTŪ), and that a period of world wide launches will now be initiated. This new, smarter...
Inhalers Beat Pill for Asthma
Daily treatment with an inhaled steroid is the best way to keep kids with asthma breathing easy.